DRUG · Bright Minds Biosciences Inc.

$68.02 -3.10 (-4.36%) At close · Sep 3

Russell 2000 member Rebalance outlook locked

Market Cap

$697.83M

9.81M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date	Event	Type
2026-06-03	Jefferies Global Healthcare Conference	Conference
2026-03-04	TD Cowen 46th Annual Health Care Conference	Conference
2026-01-06	Topline results for Phase 2 trial of BMB-101 in patients with drug-resistant Absence Seizures and Developmental and Epileptic Encephalopathy	Earnings call
2025-11-17	Jefferies Global Healthcare Conference in London	Conference
2025-11-12	Guggenheim 2nd Annual Healthcare Innovation Conference	Conference
2025-11-06	Bright Minds Prader-Willi Syndrome (PWS) Program KOL Event	Webcast
2025-06-05	2025 Jefferies Global Healthcare Conference	Conference
2025-05-21	Bright Minds Biosciences Absence Epilepsy R&D Day	Webcast
2025-03-03	TD Cowen 45th Annual Health Care Conference	Conference
2024-12-10	American Epilepsy Society 2024 Annual Meeting	Shareholder meeting
2024-11-07	Chicago BioCapital Summit	Event
2024-11-06	Bio-Europe	Event
2024-10-09	Society for Neuroscience Annual Meeting	Shareholder meeting
2024-09-25	Bright Minds Biosciences BMB-101 Phase 2 study Announcement & KOL Event	Webcast

Source: https://investors.brightmindsbio.com/

Key facts CIK 1827401 CUSIP 10919W405 13F (30d) 91 filings 90 filers Visit website Investor relations